The Multiple Faces of Lung Adenocarcinoma: Challenges in Diagnosis

1 De Alencar, V. T., Figueiredo, A. B., Corassa, M., Gollob, K. J., & C., V. (2022). Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy. Frontiers in Immunology, 13, 984349. https://doi.org/10.3389/fimmu.2022.984349; Search in Google Scholar

2 https://www.who.int/news-room/fact-sheets/detail/lung-cancer; Search in Google Scholar

3 Myers DJ, Wallen JM. Lung Adenocarcinoma. (Updated 2023 Jun 12). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519578; Search in Google Scholar

4 Pascoe HM, Knipe HC, Pascoe D, Heinze SB. The many faces of lung adenocarcinoma: a pictorial essay. J Med Imaging Radiat Oncol. 2018;62(5):654–61. - DOI – (PubMed) (Reference list); Search in Google Scholar

5 Marchetti A, Buttitta F, Pellegrini S et al. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol 1996; 179: 254–59. Search in Google Scholar

6 Murray & Nadel’s Textbook of Respiratory Medicine (7th ed.). Elsevier - OHCE. https://bookshelf.health.elsevier.com/books/9780323655897; Search in Google Scholar

7 Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011 Feb; 6(2): 244–285. Search in Google Scholar

8 Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20. PMID: 34808341. Search in Google Scholar

9 Hong SR, Hur J, Moon YW, Han K, Chang S, Kim JY, Im DJ, Suh YJ, Hong YJ, Lee HJ, Kim YJ, Choi BW. Predictive factors for treatment response using dual-energy computed tomo graphy in patients with advanced lung-adenocarcinoma. Eur J Radiol. 2018 Apr;101:118-123. doi: 10.1016/j.ejrad. 2018.02.019. Epub 2018 Feb 17. PMID: 29571784. Search in Google Scholar

10 Paliwal P, Rajappa S, Santa A, Mohan M, Murthy S, Lavanya N. Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience. Indian J Cancer. 2017 Jan-Mar;54(1): 197-202. doi: 10.4103/0019-509X.219595. PMID: 29199690. Search in Google Scholar

11 de Castro J, Tagliaferri P, de Lima VCC, Ng S, Thomas M, Arunachalam A, Cao X, Kothari S, Burke T, Myeong H, Grattan A, Lee DH. Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study. Eur J Cancer Care (Engl). 2017 Nov;26(6):e12734. doi: 10.1111/ecc.12734. Epub 2017 Jul 27. PMID: 28748556; PMCID: PMC5697695. Search in Google Scholar

12 Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, Grillo HC, Mathisen DJ. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg. 1999 Oct;118(4):702-9. doi: 10.1016/S0022-5223(99)70016-4. PMID: 10504637. Search in Google Scholar